Market
How will Quanterix's market valuation change post-Akoya acquisition by end of 2025?
2
Resolution / Starting Odds
Increase by more than 20% • 25%
Increase by 10-20% • 25%
Increase by less than 10% • 25%
Decrease • 25%
Stock market data and financial reports
Story
Quanterix to Acquire Akoya Biosciences in All-Stock Deal for First Integrated Solution in Ultra-Sensitive Biomarker Detection
Jan 10, 2025, 11:37 AM
Quanterix Corporation has reached an agreement to acquire Akoya Biosciences in an all-stock transaction. This merger aims to create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers, enhancing capabilities in disease detection at various stages. Both companies are recognized for their contributions to life sciences, with Quanterix focusing on advanced biomarker detection technologies and Akoya specializing in spatial biology solutions. The deal is expected to combine their strengths and improve diagnostic capabilities in the healthcare sector.
View original story
Similar markets
Increases by less than 10% • 25%
Increases by 10% to 20% • 25%
No significant change or decrease • 25%
Increases by more than 20% • 25%
Below $5B • 25%
$10.2B to $15B • 25%
Above $15B • 25%
$5B to $10.2B • 25%
$25 billion • 25%
$15 billion • 25%
$20 billion • 25%
Other • 25%
Increase by more than 20% • 25%
Increase by 10% to 20% • 25%
Remain within ±10% • 25%
Decrease by more than 10% • 25%
Decrease by 0-20% • 25%
Increase by 0-20% • 25%
Decrease by more than 20% • 25%
Increase by more than 20% • 25%
50% to 70% • 25%
30% to 50% • 25%
Less than 30% • 25%
More than 70% • 25%
Stock price increases by more than 20% • 25%
Stock price decreases • 25%
Stock price changes by less than 10% • 25%
Stock price increases by 10-20% • 25%
Stock remains flat or declines 0-10% • 25%
Stock declines more than 10% • 25%
Stock rises 0-10% • 25%
Stock rises more than 10% • 25%
Increase by more than 10% • 25%
No significant increase • 25%
Increase by less than 5% • 25%
Increase by 5-10% • 25%
Increase by 20% or more • 25%
Decrease • 25%
No change • 25%
Increase by less than 20% • 25%
Yes • 50%
No • 50%
Less than $50 billion • 25%
More than $70 billion • 25%
$60 billion to $70 billion • 25%
$50 billion to $60 billion • 25%